Latest filing published 30 Apr 2026 for Iradimed CORP, €214k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Roger E. Susi on record concern Iradimed Corp, in the capacity of chief executive. Between 15 November 2016 and 28 April 2026, the trades on record add up to 226 filings.
On the open market, the record shows 5 purchases worth €193k and 215 sales worth €44.7M. Taken together, the sales exceed the purchases by €44.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at no purchases and 50 sales.
Half of the purchases are above €40k and half below. No cluster: in 5 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 30 April 2026, reports an open-market sale of €214k in Iradimed Corp. The latest purchase dates back some time: it was published 3,139 days ago, on 20 March 2018. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 134 declarations